Iron deficiency and brain development

Area of Science:

• Neuroscience
• Developmental Biology
• Public Health

Background:

• Iron deficiency (ID) is a prevalent global health issue affecting pregnant women and infants.
• Rodent models demonstrate that gestational and lactational ID disrupts brain development, affecting neurometabolism, neurotransmitters, and myelination.
• Human infants with iron deficiency anemia exhibit developmental delays in cognitive, motor, and social-emotional domains.

Purpose of the Study:

• To review the impact of iron deficiency on neurodevelopment in infants and potential interventions.
• To highlight the critical window for iron intervention to mitigate long-term developmental consequences.

Main Methods:

• Review of rodent models showing neurobiological changes due to iron deficiency.
• Analysis of human infant studies assessing developmental outcomes and response to iron therapy.
• Examination of recent randomized trials on infant iron supplementation.

Main Results:

• Iron deficiency during development leads to persistent deficits in cognitive, motor, and neurophysiologic functions in human infants.
• Iron therapy outcomes are inconsistent, with long-term differences observed even after treatment.
• Fetal/neonatal ID in humans and primates is associated with poorer developmental outcomes.
• Early infant iron supplementation shows promise in preventing or reversing developmental impairments.

Conclusions:

• Protecting the developing brain from iron deficiency is crucial.
• Timely iron supplementation in infancy can prevent or reverse adverse neurodevelopmental effects.
• Early intervention is key to mitigating the long-term consequences of iron deficiency on infant brain development.